What it covered:

• VBC insights across geographies
• VBC terminology, framework, and context
• Importance of trust and early partnership

Speakers:

• Dr. Ulf Persson, PhD – Senior Advisor and former CEO of the Swedish Institute for Health Economics (IHE); Member of the board of the Swedish Dental and Pharmaceutical Benefits Agency (TLV) for 13 years
• Dr. Edmund Pezalla MD, MPH – Founder & CEO of Enlightenment Bioconsult and former Vice-President of Pharmaceutical Policy and Strategy at Aetna

What it covered:

• Theory of VBC design
• Operational contract models
• Interactive VBC design exercise

Speakers:

• Dr. Francis Fujii, MD – Medical Director at SAMU São Paulo, Brazil, and former Medical Director at Amil Health Insurer Group
• Dr. Antoni Gilabert Perramon, PharmD – Director of Innovation and Partnership at Catalan Health and Social Care Consortium

What it covered:

• Operational implementation of VBCs
• Metrics, monitoring, and capturing outcomes
• Data capabilities to support VBCs

Speakers:

• Dr. Miguel Angel Calleja, PhD, PharmD – Hospital Pharmacist / Head of Pharmacy Service at Junta de Andalucia and Director of the Clinical Trials Platform of the Granada Research Institute
• Dr. Jorge Ospina, MD – Medicines and Supplies Manager at Sanitas EPS
• Dr. Maria Carmela Piccirillo, MD – Medical Oncologist, clinical Trials Unit at National Cancer Institute, IRCCS – G. Pascale Foundation
• Marium Uddin – Senior Manager in the Managed Access Team at NICE (National Institute of Health and Care Excellence)
• Michael Rothrock – President, Allegheny Strategic Partners LLC

What it covered:

• VBC for healthcare system sustainability
• Financial flows and models

Speakers:

• Dr. Patricio Levit – Payer, private sector. Specialist in thoracic tumors, decision maker with significant experience in VBCs.
• Prof. Fei-Yuan Sharon Hsiao – Professor / Director at the Graduate Institute of Clinical Pharmacy at the National University of Taiwan (NTU)
• Yoon-Hee Choi – Expert Advisor at law firm BAE, KIM & LEE LLC and former Team Manager of Pricing & Reimbursement Evaluation at the Health Insurance Review & Assessment Service (HIRA)
• Prof. Susanne Dietrich – Professor at the Institute for Evidence-Based Positioning in the Healthcare Sector, University of Bonn and former deputy member of G-BA
• Prof. Massimo Riccaboni – Professor of Economics of IMT Lucca Institute for Advanced Studies; former professor of Economics and Management at University of Trento
• Steve Crowley – Director and Partner at LUCID Health Consulting Pty Ltd; former Executive Director of Integrated Market Access at Janssen

What it covered:

• Approach to VBC success assessment
• Equitable access to innovation
• Patient perspective on VBC benefits

Speakers:

• Dr. César Alberto Cruz – General Director of Scientific and Technical Assessment, General Health Council, Mexico
• Sir Andrew Dillon – Former Chief Executive of NICE, Chief Executive of St George’s Healthcare NHS Trust, and General Manager of the Royal Free Hospital
• Nicola Bedlington – Former Secretary General of the European Patients’ Forum, advisor to International Society for Outcomes Research, Drug Information Association, World Economic Forum Health Futures Council, International Consortium for Health Outcomes Measurement, (ICHOM). Founder partner of Millwater Partners.
• Steve Jones – President of Action for Pulmonary Fibrosis, Board of the European IPF Federation (EU-IPFF)